Indeed, PI3K/Akt inhibitors, sorafenib and TNFα are widely used in clinic to treat patients with several cancer types.37, 38, 39 Parental cancer cells were treated with either of these anticancer drugs, followed by 100 nM of VIP for 24 h. Here, AKT1 is linked to cancer.